Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2014

Open Access 01-12-2014 | Study protocol

Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trial

Authors: Rhiannon Whitaker, Jane Fossey, Clive Ballard, Martin Orrell, Esme Moniz-Cook, Robert T Woods, Joanna Murray, Jane Stafford, Martin Knapp, Renee Romeo, Barbara Woodward Carlton, Ingelin Testad, Zunera Khan

Published in: Trials | Issue 1/2014

Login to get access

Abstract

Background

People with dementia living in care homes often have complex mental health problems, disabilities and social needs. Providing more comprehensive training for staff working in care home environments is a high national priority. It is important that this training is evidence based and delivers improvement for people with dementia residing in these environments. Well-being and Health for People with Dementia (WHELD) combines the most effective elements of existing approaches to develop a comprehensive but practical staff training intervention. This optimised intervention is based on a factorial study and qualitative evaluation, to combine: training on person-centred care, promoting person-centred activities and interactions, and providing care home staff and general practitioners with updated knowledge regarding the optimal use of psychotropic medications for persons with dementia in care homes.

Design

The trial will be a randomised controlled two-arm cluster single blind trial that will take place for nine months across 80 care homes in the United Kingdom.

Discussion

The overarching goal of this trial is to determine whether this optimised WHELD intervention is more effective in improving the quality of life and mental health than the usual care provided to people with dementia living in nursing homes. This study will be the largest and best powered randomised controlled trial (RCT) evaluating the benefits of an augmented person-centred care training intervention in care homes worldwide.

Trial registration

Current controlled trials ISRCTN62237498
Date registered: 5 September 2013
Appendix
Available only for authorised users
Literature
1.
Knapp M, Prince M, Albanese E, Banerjee S, Dhanasiri S, Fernandez J-L, Ferri C, McCrone P, Snell T, Stewart R: Dementia UK. 2007, London: Alzheimer’s Society
2.
Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, Lyketsos CG: Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009, 5 (5): 245-255.CrossRefPubMed
3.
Corbett A, Smith J, Creese B, Ballard C: Treatment of behavioral and psychological symptoms of Alzheimer’s disease. Curr Treat Options Neurol. 2012, 14 (2): 113-125.CrossRefPubMed
4.
Fossey J, Masson S, Stafford J, Lawrence V, Corbett A, Ballard C: The disconnect between evidence and practice: a systematic review of person-centred interventions and training manuals for care home staff working with people with dementia. Int J Psychiatr. 2014
5.
Testad I, Corbett A, Aarsland D, Lexow KO, Fossey J, Woods B, Ballard C: The value of personalized psychosocial interventions to address behavioral and psychological symptoms in people with dementia living in care home settings: a systematic review. Int Psychogeriatr. 2014, 24: 1-16.
6.
Whitaker R, Ballard C, Stafford J, Orrell M, Moniz-Cook E, Woods R, Murray J, Knapp M, Woodward Carlton B, Fossey J: Study protocol: Feasibility study of an optimised person-centred intervention to improve mental health and reduce antipsychotics amongst people with dementia in care homes: study protocol for a randomised controlled trial. Trials. 2013, 14: 13-CrossRefPubMedPubMedCentral
7.
Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R: Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. Br Med J. 2006, 332 (7544): 756-761.CrossRef
8.
Chenoweth L, King MT, Jeon YH, Brodaty H, Stein-Parbury J, Norman R, Haas M, Lucombe G: Caring for Aged Dementia Care Resident Study (CADRES) of person-centred care, dementia-care mapping, and usual care in dementia: a cluster-randomised trial. Lancet Neurol. 2009, 8 (4): 317-325. doi:10.1016/S1474-4422(09)70045-6. Epub 2009 Mar 11CrossRefPubMed
9.
Buettner L: Simple pleasures: a multilevel sensorimotor intervention for nursing home residents with dementia. Am J Alzheimers Dis. 1999, 14: 41-CrossRef
10.
Fossey J, James I: Evidence-Based Approaches for Improving Dementia Care in Care Homes. 2008, London: Alzheimer’s Society
11.
Loveday B, Kitwood T, Bowe B: Improving Dementia Care: A Resource for Training and Professional Development. 1998, London: Hawker Publications
12.
Buettner L, Fitzsimmons S: N.E.S.T. Approach. Dementia Practice Guidelines for Disturbing Behaviors. Needs. Environment. Stimulation. Techniques. 2009, State College, PA: Venture Publishing Inc
13.
Howard R, Phillips P, Johnson T, O’Brien J, Sheehan B, Lindesay J, Bentham P, Burns A, Ballard C, Holmes C, McKeith I, Barber R, Dening T, Ritchie C, Jones R, Baldwin A, Passmore P, Findlay D, Hughes A, Macharouthu A, Banerjee S, Jones R, Knapp M, Brown RG, Jacoby R, Adams J, Griffin M, Gray R: Determining the minimum clinically important differences for outcomes in the DOMINO trial. Int J Geriatr Psychiatry. 2011, 26 (8): 812-817.CrossRefPubMed
14.
McHorney CA, Tarlow AR: Individual patient monitoring in clinical practice: are available health status surveys adequate?. Qual Life Res. 1995, 4 (4): 293-307.CrossRefPubMed
15.
Smith SC, Lamping DL, Banerjee S, Harwood RH, Foley B, Smith P, Cook JC, Murray J, Prince M, Levin E, Mann A, Knapp M: Development of a new measure of health-related quality of life for people with dementia: DEMQOL. Psychol Med. 2007, 37 (05): 737-746.CrossRefPubMed
16.
Eisen SV, Ranganathan G, Seal P, Spiro A: Measuring clinically meaningful change following mental health treatment. J Behav Health Serv Res. 2007, 34 (3): 272-289.CrossRefPubMed
17.
Russell D, Hoare ZSJ, Whitaker R, Whitaker CJ, Russell IT: Generalised method for adaptive randomisation in clinical trials. Stat Med. 2011, 30 (9): 922-934.PubMed
18.
Weiner MF, Martin-Cook K, Svetlik DA, Saine K, Foster B, Fontaine CS: The quality of life in late-stage dementia (QUALID) scale. J Am Med Dir Assoc. 2008, 1 (3): 114-116.
19.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry. 1982, 140: 566-572.CrossRefPubMed
20.
Riesberg B: Functional Assessment Staging (FAST). Psychopharmacol Bull. 1988, 24: 653-659.
21.
Reisberg B, Ferris SH, De Leon MJ, Crook T: The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatr. 1982, 139: 1136-1139.CrossRefPubMed
22.
Cohen-Mansfield J, Marx MS, Rosenthal AS: A description of agitation in a nursing home. J Gerontol Med Sci. 1989, 4: 77-84.CrossRef
23.
Lange RT, Hopp GA, Kang N: Psychometric properties and factor structure of the Neuropsychiatric Inventory Nursing Home version in an elderly neuropsychiatric population. Int J Geriatr Psychiatry. 2004, 19 (5): 440-448.CrossRefPubMed
24.
Alexopoulos GS, Abrams RC, Young RC, Shamoian CA: Cornell scale for depression in dementia. Biol Psychiatry. 1988, 23: 271-284.CrossRefPubMed
25.
Abbey J, De Bellis A, Piller N, Esterman A, Giles L, Parker D, Lowcay B: The Abbey pain scale: a 1-minute numerical indicator for people with end-stage dementia. Int J Palliat Nurs. 2004, 10: 1-CrossRef
26.
Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001, 33 (5): 337-343.CrossRefPubMed
27.
Reynolds T, Thornicroft G, Abas M, Woods B, Hoe J, Leese M, Orrell M: Camberwell Assessment of Need for the Elderly (CANE): development, validity and reliability. Br J Psychiatry. 2000, 176: 444-452.CrossRefPubMed
28.
Beecham J, Knapp M: Costing Psychiatric Interventions. Measuring Health Needs. Edited by: Thornicroft G. 2001, London: Gaskell, 200-224. 2
29.
Dean R, Proudfoot R, Lindesay J: The Quality of Interaction Schedule (QUIS): development, reliability and use in the evaluation of two domus units. Int J Geriatr Psychiatry. 1993, 8: 819-826.CrossRef
30.
31.
Carpenter JR, Kenward MG: Missing Data in Clinical Trials - A Practical Guide Birmingham. National Institute for Health Research. 2008
Metadata
Title
Improving Well-being and Health for People with Dementia (WHELD): study protocol for a randomised controlled trial
Authors
Rhiannon Whitaker
Jane Fossey
Clive Ballard
Martin Orrell
Esme Moniz-Cook
Robert T Woods
Joanna Murray
Jane Stafford
Martin Knapp
Renee Romeo
Barbara Woodward Carlton
Ingelin Testad
Zunera Khan
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Trials / Issue 1/2014
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-15-284

Other articles of this Issue 1/2014

Trials 1/2014 Go to the issue

Study protocol

Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial

Research

Clear obstacles and hidden challenges: understanding recruiter perspectives in six pragmatic randomised controlled trials

Study protocol

HALT-IT - tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial

Study protocol

Pilot study evaluating broccoli sprouts in advanced pancreatic cancer (POUDER trial) - study protocol for a randomized controlled trial

Study protocol

Furosemide and albumin for diuresis of edema (FADE): a study protocol for a randomized controlled trial

Study protocol

Mechanochemical endovenous Ablation versus RADiOfrequeNcy Ablation in the treatment of primary great saphenous vein incompetence (MARADONA): study protocol for a randomized controlled trial